every biotech is said to have long term potential. we hear it all the time. the fact is most biotechs rise on absolutely nothing. less than 5-10% of biotechs ever ship a product to market, yet far more than 10% surge. we have seen doubles and triples on companies that will NEVER turn a profit ever, never be bought out. ino surged 150% on the mere rumor it would be bought out by merk, that is all!
i like zlcs because it has multiple catalysts and doesnt have a history of jerking their shareholders around. they dont lie, and are open about the potential for an RS - having already appproved one if the time comes. we know zlcs will be above 1.00 before october because shareholders and investors dont want to see an RS. so if you buy now you are guaranteed some level of profit